Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s code of conduct for regulating, monitoring and reporting of trading by insiders, Indoco Remedies has informed that the Trading Window for trading/dealing in Equity Shares of the Company will remain closed from 01st January, 2025 until 48 hours after declaration of Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December, 2024. During the closure of trading window, all designated persons of the Company (including their immediate relatives) have been advised not to deal in Equity Shares of the Company. The date of the Board Meeting of the Company for declaration of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2024, will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
